Evidence map›Paper›PMID 40055655›Full record

ArticleBMC ophthalmology2025

The effects of lower eyelid epiblepharon surgery on the meibomian glands.

Seongmi Kim, Da Eun Yoon, Hyun Sun Jeon, Namju Kim

Abstract read
In one paragraph

Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Seongmi Kim *Department of Ophthalmology, Jeju National University College of Medicine, Jeju-si, Korea.
Da Eun Yoon *Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea.
Hyun Sun Jeon *Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea. jeonhs@snu.ac.kr.
Namju Kim *Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea. resourceful@hanmail.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo investigate the morphological and functional changes of meibomian glands (MG) in pediatric patients who underwent surgery for lower eyelid epiblepharon.

methodsA total of 176 eyes of 88 patients aged 19 and under (mean age: 8.9 ± 2.8 years old) who underwent bilateral lower eyelid epiblepharon correction surgery from May 2022 to April 2023 were included. Meibograde, lipid layer thickness (LLT), total blink rate, and corneal/refractive astigmatism were compared between pre- and 2 months postoperatively.

resultsThere were no statistically significant changes in meibograde and LLT after surgery. The total blink rate was significantly decreased after surgery (p = 0.02). While corneal and refractive astigmatism showed no significant changes in total eyes, corneal astigmatism in eyes of high astigmatism of 2.0D or more subgroup exhibited a significant decrease postoperatively (p < 0.001).

conclusionsLower eyelid epiblepharon surgery in pediatric patients does not significantly alter the structure and function of the MG. Additionally, stabilizing the ocular surface through surgical correction may have beneficial effects on blink rate and corneal astigmatism. Although the long-term evaluation would be needed, we suggest that lower eyelid epiblepharon surgery could be performed without worrying about adverse effects on the MG.

Indexed as

BlepharoplastyEyelid DiseasesEyelidsMeibomian GlandsAdolescentAstigmatismBlinkingChildChild, PreschoolFemaleHumansMaleOphthalmologic Surgical ProceduresRetrospective StudiesTearsYoung AdultAstigmatismEpiblepharonMeibographyMeibomian gland

Identifiers

PMID40055655
PMCPMC11887093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.